Antisense RNA Compounds
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
56
NCT06300307
Study of ATX-01 in Participants With DM1
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 15, 2024
Completion: Jun 30, 2026
Loading map...